Ligand Pharmaceuticals (LGND) Receivables - Other (2010 - 2015)
Ligand Pharmaceuticals' Receivables - Other came in at $88,000 for Q1 2015, down 87.2% from $688,000 a year earlier and down 72.7% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Receivables - Other (2010 - 2015) Analysis & Trends
At the end of FY2014, Ligand Pharmaceuticals' Receivables - Other was $322,000, down 92.6% from FY2013.
- Receivables - Other carries a four-year compound annual growth rate of -55.3% (FY2010 to FY2014).
- Going back by year, Receivables - Other was $4.33 million in FY2013 (unchanged), $4.33 million in FY2012 (-30.2%), $6.2 million in FY2011 (-22.9%) and $8.03 million in FY2010.
- The Q1 2015 figure represents the lowest quarterly Receivables - Other in data going back to Q4 2010.
- Year-over-year, Receivables - Other has declined for five consecutive quarters, with an average decline of 56.4% over the last eight quarters.
- The fastest year-over-year change in Receivables - Other over five years came in Q3 2013 (growth of 1.7%), and the weakest in Q4 2014 (a decline of 92.6%).
- Business Quant data shows LGND's Receivables - Other at $322,000 (Q4 2014), $523,000 (Q3 2014) and $391,000 (Q2 2014) in the three quarters before Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 88,000.00 |
| Dec 31, 2014 | 322,000.00 |
| Sep 30, 2014 | 523,000.00 |
| Jun 30, 2014 | 391,000.00 |
| Mar 31, 2014 | 688,000.00 |
| Dec 31, 2013 | 4.33 Mn |
| Sep 30, 2013 | 4.51 Mn |
| Jun 30, 2013 | 4.47 Mn |
| Mar 31, 2013 | 4.26 Mn |
| Dec 31, 2012 | 4.33 Mn |
| Sep 30, 2012 | 4.43 Mn |
| Jun 30, 2012 | 4.93 Mn |
| Mar 31, 2012 | 5.90 Mn |
| Dec 31, 2011 | 6.20 Mn |
| Sep 30, 2011 | 8.03 Mn |
| Jun 30, 2011 | 8.03 Mn |
| Dec 31, 2010 | 8.03 Mn |
API Access
Ligand Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();